2026 Flora E. van Leeuwen: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	104	6984	6570	264	258	437	46033

Overview

Flora E. van Leeuwen is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their work primarily focuses on the field of medicine with a strong emphasis on oncology and related subfields.

The scientist's research spans 292 publications in medicine, including significant contributions in the following subfields:

Oncology
Pediatrics, Perinatology and Child Health
Pathology and Forensic Medicine
Genetics
Surgery

Key topics addressed in van Leeuwen's work include:

Childhood Cancer Survivors' Quality of Life
Cancer Risks and Factors
BRCA gene mutations in cancer
Lymphoma Diagnosis and Treatment
Breast Cancer Treatment Studies
Genetic factors in colorectal cancer
Chemotherapy-induced cardiotoxicity and mitigation

Their recent papers cover various aspects of cancer surveillance, risk assessment, and treatment, notably:

Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer (2020), published in Journal of Clinical Oncology
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients (2020), published in JNCI Journal of the National Cancer Institute
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study (2021), published in JNCI Journal of the National Cancer Institute
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (2020), published in Breast Cancer Research
Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma (2020), published in Blood

Van Leeuwen frequently publishes in several prominent journals, with the highest number of contributions in:

Journal of Clinical Oncology
JNCI Journal of the National Cancer Institute
Human Reproduction
HemaSphere
Cancer

Their collaborative work includes partnerships with several frequent co-authors, notably:

Michael Schaapveld
Berthe M.P. Aleman
Leontien C.M. Kremer
Cécile P.M. Janus
Cécile M. Ronckers

Best Publications

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips

2526
Citations
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

1453
Citations
Medical assessment of adverse health outcomes in long-term survivors of childhood cancer

Maud M. Geenen;Mathilde C. Cardous-Ubbink;Leontien C. M. Kremer;Cor van den Bos

1112
Citations
Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

Maartje J. Hooning;Akke Botma;Berthe M. P. Aleman;Margreet H. A. Baaijens

982
Citations
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease

Berthe M.P. Aleman;Alexandra W. van den Belt-Dusebout;Willem J. Klokman;Mars B. van’t Veer

952
Citations
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch

916
Citations
Late cardiotoxicity after treatment for Hodgkin lymphoma

Berthe M. P. Aleman;Alexandra W. van den Belt-Dusebout;Marie L. De Bruin;Mars B. van 't Veer

838
Citations
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

Lois B. Travis;Deirdre A. Hill;Graça M. Dores;Mary Gospodarowicz

779
Citations
Risk of endometrial cancer after tamoxifen treatment of breast cancer

F.E. van Leeuwen;A.W. van den Belt-Dusebout;J. Benraadt;F.W. Diepenhorst

719
Citations
Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

Graça M. Dores;Catherine Metayer;Rochelle E. Curtis;Charles F. Lynch

666
Citations
Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease

Lois B. Travis;Mary Gospodarowicz;Rochelle E. Curtis;E. Aileen Clarke

664
Citations
Health Council of the Netherlands: No need to change from SAR to time-temperature relation in electromagnetic fields exposure limits

G.C. van Rhoon;A. Aleman;G. Kelfkens;H. Kromhout

617
Citations
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

Lois B. Travis;Rochelle E. Curtis;Joseph F. Fraumeni;John D. Boice

602
Citations
Risk and prognosis of endometrial cancer after tamoxifen for breast cancer

Liesbeth Bergman;Maureen L R Beelen;Maarten P W Gallee;Harry Hollema

595
Citations
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Michael Schaapveld;Berthe M.P. Aleman;Anna M. van Eggermond;Cécile P.M. Janus

590
Citations
Leukemia following Hodgkin's disease.

Kaldor Jm;Day Ne;Clarke Ea;Van Leeuwen Fe

553
Citations
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.

Flora E. van Leeuwen;Willem J. Klokman;Mars B. van t Veer;Anton Hagenbeek

548
Citations
Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Alexandra W. van den Belt-Dusebout;Ronald de Wit;Jourik A. Gietema;Simon Horenblas

510
Citations
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

Lois B. Travis;Deirdre Hill;Graça M. Dores;Mary Gospodarowicz

508
Citations
Risk and Prognosis of Endometrial Cancer After Tamoxifen for Breast Cancer

L. R. Beelen;Maarten P. W. Gallee;Harry Hollema;Jantien Benraadt

2
Citations

Frequent Co-Authors

Marjanka K. Schmidt Antoni van Leeuwenhoek Hospital

Laura J. van't Veer University of California, San Francisco

Douglas F. Easton University of Cambridge

Annegien Broeks Antoni van Leeuwenhoek Hospital

Antonis C. Antoniou University of Cambridge

Otto Visser VU University Medical Center

Roger L. Milne Cancer Council Victoria

Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital

Marilyn Stovall The University of Texas MD Anderson Cancer Center

David E. Goldgar University of Utah

External Links

Personal website of Flora E. van Leeuwen

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to a range of flexible, accelerated online nursing and healthcare degrees. For those seeking advanced roles, accelerated msn to dnp programs offer a fast-tracked path from a Master of Science in Nursing (MSN) to the highest clinical nursing degree (DNP), often designed for working professionals who want career advancement.

Budget-conscious students may benefit from exploring the cheapest dnp program options online. These programs make it easier for students to acquire a high-demand credential without overwhelming student debt, broadening access to advanced practice positions.

If you are starting your nursing journey, a lpn accelerated program provides an efficient entry point to the healthcare workforce in months rather than years. For those interested in mental health, the fastest psych np program offers direct advancement to becoming a Psychiatric-Mental Health Nurse Practitioner—meeting a growing area of demand.

These online degree options support diverse career ambitions, allowing future healthcare leaders to tailor their education and fast-track their professional growth.